Keyser Soze Wrote in message:
On 8/27/16 9:52 PM, Tim wrote:
Actually I hope this inspires competition.



Ahhh...that old American dream...the "free market" and "competition."

One of my neighbors is diabetic and earlier this week when the Epipen
scandal broke, he mentioned that two insulin products he has used,
Novolog something or other and Humalog something or other, from two
competing manufacturers, had "list prices" of around $1100 for a one
month supply. He pays less because of his insurance, but he still pays a
lot. No competition in price. It's the American way for many products.
Competition is not the answer.

I doubt the Epipens cost more than $2 or $3 to manufacture, including
the drug and the injector. I read a report that in Canada, a Canadian in
need of an Epipen pays about $12.




Rumor has it that the predecessor to the new improved pen is off
patent protection, .and at least one fella has figgered out how
to reuse the device. The drug itself is dirt cheap. Won't be long
before Epipens become the new Lipitor. Might be interesting to
find out profit margins figureing in development and other costs
to market the Epipen. Or you could go with your gut feelings
about how much profit YOU summise a company should make. How much
profit does your product produce? I'd bet around 99.5 percent.
How worthwhile is it? Talk about the king of ripoffs. You da
man.
--
x


----Android NewsGroup Reader----
http://usenet.sinaapp.com/